Company
Venus Concept
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
17
510(k), De Novo and PMA
Device trials
33
As lead sponsor, any status
Adverse event reports
6
Received Nov 1, 2025 to Nov 20, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$65.8M
10 Form D offerings, 2017 to 2026
Equity
$64.7M
Stock sold for cash
Debt and convertible notes
$0
Loans and notes sold to investors
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $1.5M raised of $1.5M sought, first sale Mar 26, 2026, 2 investors. $1.1M was in other or unstated securities.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Equity | $1.5M | $1.5M | 2 | Rule 506(b) | Form D ↗Apr 9, 2026 |
| Feb 27, 2024 | Options or warrants | $1.1M | $1.1M | 2 | Rule 506(b)Agent: H.C. Wainwright & Co., LLCCommissions $84K | Form D ↗Mar 7, 2024 |
| May 15, 2023 | Equity | $2.0M | $9.0M | 2 | Rule 506(b) | Form D ↗May 24, 2023 |
7 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- Venus Concept Inc.; Venus Concept Ltd.
- Headquarters
- Toronto, Ontario, Canada
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1409269 ↗, CIK 1649064 ↗
Executives, directors and promoters
As listed on the latest Form D.
8 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Venus Concept.
Latest FDA decisions
The 8 newest of 17 since 2015.
- Venus Nova (FP-2001)510(k)
K252845 · Decided Nov 6, 2025 · 59 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
- Venus Versa PRO System510(k)
K232192 · Decided Sep 11, 2023 · 49 days after receipt
Device type: Powered Light Based Non-Laser Surgical Instrument With Thermal Effect (ONF) · General & Plastic Surgery
- AI.ME System510(k)
K221011 · Decided Dec 20, 2022 · 259 days after receipt
Device type: Powered Microneedle Device (QAI) · General & Plastic Surgery
14 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT05897723 · 20 participants (planned) · Start Sep 1, 2023 · Primary completion May 31, 2025
Device: Fractional Radiofrequency · For: Surgical Incision
Sites: Dallas, Texas
- Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.Active, not recruiting
NCT05256771 · 36 participants (planned) · Start Nov 1, 2021 · Primary completion Jul 31, 2025
Device: EMS; 1064 nm diode laser and 1 more · For: Fat Reduction; Muscle Tone Increased
Sites: San Diego, California; Hackensack, New Jersey; Nashville, Tennessee
NCT05938569 · 150 participants (planned) · Start Nov 3, 2016 · Primary completion Dec 15, 2026
Device: Hair restoration · For: Androgenic Alopecia
Sites: Los Altos, California; San Jose, California
30 more trials with a free account
Reports received
6
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
1
17% of reports
Injury reports
5
83% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 1 | 0 | 0 | 0 |
| Apr 24 | 0 | 2 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 1 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 1 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 1 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 2 | 0 | 0 |
| Dec 25 | 0 | 1 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 1 | 1 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
2 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.